Unexpected toxicities identified with concomitant HIV, TB treatment use

Combining dolutegravir with isoniazid plus rifapentine may lead to serious side effects, including flu-like syndrome and elevated transaminase levels. The findings come from a drug-drug interaction study conducted by researchers at the National Institute of Health and Colorado State University.

Read More →

Tuberculosis vaccine may carry dermatological benefits for newborns

Bacillus Calmette-Guérin (BCG) vaccination within 7 days of birth may reduce the risk of allergic diseases, including atopic dermatitis, according to a study published online September 20 in Allergy.

Read More →

Page 1 of 1 · Total posts: 2